With CMS’ release of the Contract Year 2021 Final Rule, MA plans now have some clarity regarding the many Star Ratings proposals made earlier this year.
Tag: Medicare Advantage
With MA enrollment soaring, COVID-19 presenting still-developing threats to Medicare, and the Medicare Trust fund approaching insolvency, MedPAC continued emphasizing the need for urgently reforming the MA Quality Bonus Program during its April 2nd public meeting.
In the fall, plans will be challenged by the double whammy of a presidential election and a predicted second outbreak of COVID-19. This AIS Health article in Health Plan Weekly shares some insights from a recent GHG/Deft Research webinar and the product strategy implications of a changed selling environment.
In a recent webinar presented with Deft Research, GHG shared the key lessons learned from the 2020 AEP results. Read a synopsis of what these lessons entail and watch the webinar recording on demand.
The 2021 Medicare Advantage and Part D Rate Announcement finalizes the payment methodology and policies previously proposed by the Advance Notice. What’s been confirmed? Read this article for details.
In a recent webinar, GHG shared the critical trends in supplemental benefits from the AEP results data that health plans need to know going into 2021 bids. Read a summary of the key takeaways and view the webinar recording on demand.
On March 30, 2020, CMS announced temporary regulatory waivers and new rules to help the U.S. healthcare system continue operating through President Trump’s COVID-19 emergency declaration. With this new information, GHG’s Star Ratings expert, Melissa Smith, answers many of the FAQs we’ve received over the last few weeks.
CMS recently broadened access and greatly relaxed regulations around telehealth services for Medicare beneficiaries. What does this mean for Medicare Advantage plans and providers?
Right now, the industry is wrought with uncertainty and awaiting specific rulemaking from CMS in regard to the Star Ratings program. Read more for our suggestions on what clients can, and should, be doing from a Stars perspective in the midst of the COVID-19 crisis.
The Office of Inspector General (OIG) report on the use of chart reviews in Medicare Advantage risk adjustment raises a number of concerns for Medicare Advantage Organizations (MAOs). How can plans mitigate risk from chart review submissions and stay compliant with CMS risk adjustment guidelines to ensure complete and accurate reimbursement?